Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Change in Accured Expenses (2016 - 2026)

Lexaria Bioscience's Change in Accured Expenses history spans 12 years, with the latest figure at -$1.2 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$1.2 million for Q1 2026, down 181.55% from a year ago — trailing twelve months through Feb 2026 was -$1.6 million (down 192.68% YoY), and the annual figure for FY2025 was $396637.0, down 52.01%.
  • Change in Accured Expenses for Q1 2026 was -$1.2 million at Lexaria Bioscience, down from -$37613.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.5 million in Q1 2025 to a low of -$1.2 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is -$37613.0 (2025), against an average of -$407.82.
  • The sharpest move saw Change in Accured Expenses crashed 13829.01% in 2023, then soared 3591.7% in 2025.
  • Year by year, Change in Accured Expenses stood at $90442.0 in 2022, then crashed by 255.87% to -$140973.0 in 2023, then crashed by 465.66% to -$797423.0 in 2024, then surged by 95.28% to -$37613.0 in 2025, then crashed by 3204.24% to -$1.2 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.2 million, -$37613.0, and $4787.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.